review·The Lancet Infectious Diseases·Aug 8, 2022BRONZE OA

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

NINatalie I MazurJTJonne TerstappenRBRanju BaralABAzucena BardajíPBPhilippe Beutels

University Medical Center Utrecht · Wilhelmina Children's Hospital · +35 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

430
total citations
FWCI
63.63
Percentile
100%
References
86
Citations per year

Authors

41
  • NI
    Natalie I Mazur

    University Medical Center Utrecht, Wilhelmina Children's Hospital

  • JT
    Jonne Terstappen

    University Medical Center Utrecht, Wilhelmina Children's Hospital

  • RB
    Ranju Baral

    Program for Appropriate Technology in Health

  • AB
    Azucena Bardají

    Universitat de Barcelona, Barcelona Institute for Global Health, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Manhiça Health Research Centre

  • PB
    Philippe Beutels

    University of Antwerp, UNSW Sydney

Topics & keywords

Topics
  • Primary topicRespiratory viral infections research100%
  • Neonatal Respiratory Health Research99%
  • Pneumonia and Respiratory Infections99%
Keywords
  • Monoclonal antibody
  • Virology
  • Virus
  • Medicine
  • Palivizumab
  • Immunology
  • Antibody
  • Epitope
No related works found for this paper.

Funding

  • P
    Pfizer
  • M
    Merck
  • NI
    National Institutes of Health
  • SP
    Sanofi Pasteur
  • NI
    National Institute of Allergy and Infectious Diseases
  • JP
    Janssen Pharmaceuticals